Deal Announcements

ArmaGen Technologies Nets Series A Venture Capital

Tuesday, December 04, 2012 5:35:00 AM PDT | VentureDeal

   Santa Monica, California  --  Biotechnology company ArmaGen Technologies has raised $17 million in its first institutional venture capital financing.

ArmaGen is developing technologies that can "non-invasively target recombinant proteins, therapeutic monoclonal antibodies and siRNA to the brain."

A number of corporate and venture capital firms participated in the financing.

The company said it would use the proceeds to begin clinical trials of its lead candidate.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1